Eur Heart J

Jan 14 2026

Long-term outcome and predictors for recurrence after medical and interventional treatment of arrhythmias at the UniverSity Heart CenTer Hamburg (TRUST): design and patient profile snapshot of a prospective clinical cohort study

Obergassel J, Rieß JL, Jaeckle S, van Elferen S, Nies M, Schenker N, Lemoine MD, Welcker A, Kany S, Rottner L, Ismaili D, Sommerfeld LC, Petersen J, Govorov K, Schoof L, Tsoy O, Baumbach J, Pecha S, Zeller T, Blankenberg S, Fabritz L, Reißmann B, Ouyang F, Rillig A, Metzner A, Kirchhof P.

Eur Heart J Open. 2026 Jan 14; 6(1):oeag002. eCollection 2026 Jan. PMID: 41743284

https://pubmed.ncbi.nlm.nih.gov/41743284/

Apr 22 2025

Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial

Eur Heart J, Publications

Angermann CE, Sehner S, Gerhardt LMS, Santos-Gallego CG, Requena-Ibanez JA, Zeller T, Maack C, Sanz J, Frantz S, Ertl G, Badimon JJ.

Eur Heart J. 2025 Apr 22;46(16):1507-1523. doi: 10.1093/eurheartj/ehae917. PMID: 39907687

https://pubmed.ncbi.nlm.nih.gov/39907687/

Dec 1 2020

The ACCOST-HH Trial.

Eur Heart J, Publications

Skurk C, Rottbauer W, Kessler M, Akin I, Kluge S, Burdelski C, Blankenberg S, Zeller T, Landmesser U, Karakas M.

Eur Heart J. 2020 Dec 1;41(45):4296-4298. doi: 10.1093/eurheartj/ehaa757. PMID: 33111142.

https://pubmed.ncbi.nlm.nih.gov/33111142

Jun 14 2020

Clinical application of the 4th Universal Definition of Myocardial Infarction.

Eur Heart J, Publications

Hartikainen TS, Sörensen NA, Haller PM, Goßling A, Lehmacher J, Zeller T, Blankenberg S, Westermann D, Neumann JT.

Eur Heart J. 2020 Jun 14;41(23):2209-2216. doi: 10.1093/eurheartj/ehaa035. PMID: 32077925

https://pubmed.ncbi.nlm.nih.gov/32077925/

Research

Team

Publications

Institute Updates

Long-term outcome and predictors for recurrence after medical and interventional treatment of arrhythmias at the UniverSity Heart CenTer Hamburg (TRUST): design and patient profile snapshot of a prospective clinical cohort study

Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial

The ACCOST-HH Trial.

Clinical application of the 4th Universal Definition of Myocardial Infarction.

Institute for Cardiogenetics

About Us

Information